Pannetier Maëlle, Feil Robert
Institute of Molecular Genetics, CNRS, 1919, route de Mende, 34293 Montpellier, France.
Trends Biotechnol. 2007 Dec;25(12):556-62. doi: 10.1016/j.tibtech.2007.09.003. Epub 2007 Nov 5.
Recent studies highlight the tremendous potential of human embryonic stem (ES) cells and their derivatives as therapeutic tools for degenerative diseases. However, derivation and culture of ES cells can induce epigenetic alterations, which can have long lasting effects on gene expression and phenotype. Research on human and mouse stem cells indicates that developmental, cancer-related genes, and genes regulated by genomic imprinting are particularly susceptible to changes in DNA methylation. Together with the occurrence of genetic alterations, epigenetic instability needs to be monitored when considering human stem cells for therapeutic and technological purposes. Here, we discuss the maintenance of epigenetic information in cultured stem cells and embryos and how this influences their developmental potential.
近期研究突显了人类胚胎干细胞(ES细胞)及其衍生物作为退行性疾病治疗工具的巨大潜力。然而,ES细胞的获取和培养会诱导表观遗传改变,这可能对基因表达和表型产生持久影响。对人类和小鼠干细胞的研究表明,发育相关基因、癌症相关基因以及受基因组印记调控的基因尤其容易受到DNA甲基化变化的影响。在考虑将人类干细胞用于治疗和技术目的时,除了遗传改变的发生,还需要监测表观遗传不稳定性。在此,我们讨论培养的干细胞和胚胎中表观遗传信息的维持,以及这如何影响它们的发育潜能。